APA (7th ed.) Citation

BJ, A., T, B., M, M., G, H., S, M., J, R., . . . AM, B. (2025). A phase I clinical trial of lenalidomide combined with bortezomib for acute myeloid leukemia or myelodysplastic syndrome relapsing after allogeneic stem cell transplantation. Leukemia research, 153, 107693. https://doi.org/10.1016/j.leukres.2025.107693

Chicago Style (17th ed.) Citation

BJ, Aubrey, et al. "A Phase I Clinical Trial of Lenalidomide Combined with Bortezomib for Acute Myeloid Leukemia or Myelodysplastic Syndrome Relapsing After Allogeneic Stem Cell Transplantation." Leukemia Research 153 (2025): 107693. https://doi.org/10.1016/j.leukres.2025.107693.

MLA (9th ed.) Citation

BJ, Aubrey, et al. "A Phase I Clinical Trial of Lenalidomide Combined with Bortezomib for Acute Myeloid Leukemia or Myelodysplastic Syndrome Relapsing After Allogeneic Stem Cell Transplantation." Leukemia Research, vol. 153, 2025, p. 107693, https://doi.org/10.1016/j.leukres.2025.107693.